# Photodynamic Therapy for Cholangiocarcinoma

> **NCT04860154** · NA · COMPLETED · sponsor: **Hepatopancreatobiliary Surgery Institute of Gansu Province** · enrollment: 86 (actual)

## Conditions studied

- Cholangiocarcinoma Non-resectable

## Interventions

- **DRUG:** Hematoporphyrin

## Key facts

- **NCT ID:** NCT04860154
- **Lead sponsor:** Hepatopancreatobiliary Surgery Institute of Gansu Province
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-17
- **Primary completion:** 2024-11-19
- **Final completion:** 2024-11-19
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2024-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04860154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04860154, "Photodynamic Therapy for Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04860154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*